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Epilepsy is a brain disorder which affects about 50 million people worldwide. Ineffectiveness of the drugs in some cases and the
serious side effects and chronic toxicity of the antiepileptic drugs lead to use of herbal medicine as a form of complementary
and alternative medicine. In this review modern evidences for the efficacy of antiepileptic medicinal plants in Traditional Iranian
Medicine (TIM) will be discussed. For this purpose electronic databases including PubMed, Scopus, Sciencedirect, and Google
Scholar were searched for each of the antiepileptic plants during 1970-February 2013.Anticonvulsant effect of some of themedicinal
plants mentioned in TIM like Anacyclus pyrethrum, Pimpinella anisum, Nigella sativa, and Ferula gummosa was studied with
different models of seizure. Also for some of these plants like Nigella sativa or Piper longum the active constituent responsible for
antiepileptic effect was isolated and studied. For some of the herbal medicine used in TIM such as Pistacia lentiscus gum (Mastaki),
Bryonia alba (Fashra), Ferula persica (Sakbinaj), Ecballium elaterium (Ghesa-al Hemar), and Alpinia officinarum (Kholanjan) there
is no or not enough studies to confirm their effectiveness in epilepsy. It is suggested that an evaluation of the effects of these plants
on different epileptic models should be performed.
1. Introduction
Epilepsy is a brain disorder which is characterized by occur-
rence of spontaneous seizures induced by a complex of
neurotransmitter systems. It is one of the most common
neurological disorders which affects about 50 million people
worldwide [1]. It is estimated that about 1% of people through
the word suffer from epilepsy [2]. Epilepsy can commonly
be controlled with modern anticonvulsants which prevent
the seizures or reduce their intensity. However, over 30% of
people with epilepsy have uncontrolled seizures even with
the best available drugs, but there is some difficulty in the
treatment procedure of epilepsy, for example, ineffectiveness
of the drugs in nearly 20% of the cases and the serious
side effects and chronic toxicity of the drugs [3]. Therefore
there is an increasing interest to use natural sources which
would be a valuable agent for finding the new therapeutic
drugs. On the other hand, theWorldHealthOrganization has
estimated that perhaps 80% of the world’s population relies
chiefly on traditionalmedicine for primary health care needs.
Although, most of the herbal and complementary medicines
are usedwithout adequate evidence of benefit and safety from
controlled clinical trials.
The ancient Iranian medicine was combined by different
medical traditions from Greece, Egypt, India, and China for
more than 4000 years. TIM consists of the sum total of all
the knowledge and practices used in diagnosis, prevention,
and elimination in Persia from ancient times to present.There
is information and data in Traditional Iranian documents
or books about medicinal herbs which are used by TIM
scientists for the treatment of epilepsy [4].
In this study, we reviewed the herbal treatments for
epilepsy mentioned by TIM documents and text and com-
pared them with the recent scientific literature.
2. Materials and Methods
In this paper, we reviewed themost important ancient Herbal
treatments for epilepsy mentioned by the most famous TIM
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books like Makhzan, Tohfeh, Tebe Akbari, and Moalejate
Aghili, and considered this medicinal herbs as the key
words for the next step of our study [5–8]. Then electronic
databases including PubMed, Scopus, ScienceDirect, and
Google Scholar were searched for each of the plants in TIM
plus epilepsy, anticonvulsant, or seizure as the keywords.
These results revealed new scientific findings in modern
medicine about the TIM recommendations for epilepsy
in order to design future scientific studies based on the
suggested herbal therapies for epilepsy.
3. Results
There are some medicinal plants which were used in TIM for
the treatment of epilepsy. The results showed that there are
scientific evidences for antiepileptic effects of some of these
plants in the literature (Table 1).
3.1. Modern Evidence for the Efficacy of Medicinal Plants in
TIM Used for the Treatment of Epilepsy
3.1.1. Terminalia chebula. “Halile siah” is the black fruit of
Terminalia chebula which has been used in TIM for the
treatment of epilepsy. The anticonvulsant activity of the
ethanolic extract of Terminalia chebula (200 and 500mg/kg
p.o.) was investigated in albino mice by the use of maximum
electroshock seizure (MES) test, pentylenetetrazole (PTZ),
and picrotoxin test.
The findings of the study revealed that the ethanolic
extract of Terminalia chebula significantly reduced the dura-
tion of seizures induced by MES. The ethanol extract in
doses of 200 and 500mg/kg conferred protection (17 and
50%, resp.) on the mice. The same doses also protected
animals from PTZ-induced tonic seizures and significantly
delayed the onset of tonic seizures produced by picrotoxin.
So the ethanolic extract of Terminalia chebula possesses
anticonvulsant activity in mice [9].
3.1.2. Pimpinella anisum. Anisun is a traditional name of
Pimpinella anisum seeds that has been used for the treatment
of epilepsy in TIM. The seeds (fruits) of this plant have been
studied for anticonvulsant activity. The effects of an essential
oil of the fruits of Pimpinella anisum against seizures induced
by PTZ or MES were investigated in male mice. The essen-
tial oil suppressed hind limb tonic extensions (HLTE) and
mortality in PTZ-induced seizure (ED
50
= 0.52mL/Kg) and
MES-induced seizure (ED
50
= 0.2mL/Kg). It also elevated the
threshold of PTZ-induced clonic convulsions in mice [14].
Also the methanolic extract of the anise seeds in doses of
12.5–400mg/Kg was investigated for anticonvulsant activity
in mice using Picrotoxin model. The results revealed that
the extract showed a significant anticonvulsant activity in a
dose of 200mg/Kg compared to the control groups [15]. In
another study antiseizure and antihypoxia effects of anise oil
were studied on PTZ model and neuronal hypoxia induced
by oxygen withdrawal as well as on the production of dark
neurons and induction of long-term potentiation (LTP) in
vivo and in vitro experimental models of rat brain. Anise
oil significantly prolonged the latency of seizure attacks and
reduced the amplitude and duration of epileptiform burst
discharges induced by the injection of PTZ. In addition, anise
oil significantly inhibited the production of dark neurons
in different regions of the brain in epileptic rats. Anise oil
also significantly enhanced the duration of the appearance of
anoxic terminal negativity induced by oxygenwithdrawal and
inhibited the induction of LTP in hippocampal slices. So this
study indicates anticonvulsant and neuroprotective effects of
anise oil [16, 17].
3.1.3. Anacyclus pyrehrun. Anacyclus pyrethrum, known as
“Agher Gherha” in TIM, is another drug used in TIM for
the treatment of epilepsy and seizure. In a study by Zaidi
et al. anticonvulsant, antioxidant, and neuropharmacological
activities of the chloroform fraction of Anacyclus pyrethrum
roots at a dose range of 100–800mg/kg (i.p.) were evaluated
in mice. PTZ and increasing current electroshock (ICES)
models were used.The chloroform fraction significantly (𝑃 <
0.001) delayed the onset of PTZ-induced seizures. ICES
test results significantly increased the seizure threshold. This
fraction also causes a reduction in the formation of lipid per-
oxidation products but did not show antianxiety and antide-
pressant effects. The results indicate potential antiseizure
activity of chloroform fraction of Anacyclus pyrethrum root
extract along with additional neuropharmacological effects
[10].
The anticonvulsant and myorelaxation activities of A.
pyrethrum root ethanolic extract were evaluated in albino
mice using MES model and rotarad test, respectively. The
extract was prescribed in doses of 200, 400, and 600mg/kg
i.p. and compared with control groups (group I, vehicle
treated, group II, phenytoin treated). The extract of A.
pyrethrum reduced the duration of hind limb tonic extension
in a dose-dependent manner in MES model [11]. In another
study the effect of hydroalcoholic extract ofA. pyrethrum root
extract was studied against seizures, seizure-induced oxida-
tive stress, and cognitive impairment in maleWistar rats.The
extract was administered in doses of 50, 100, 250, and 500
in PTZ model and 250, 500, and 1000mg/kg in MES model.
Myoclonic jerk latency and generalized tonic clonic seizures
(GTCS) were noted in PTZ whereas occurrence of tonic hind
limb extension (THLE) was observed in MES seizures. Cog-
nitive deficit was assessed using the elevated plus maze and
passive avoidance tests. Whole brain reduced glutathione,
malondialdehyde levels and cholinesterase activity weremea-
sured. In the PTZ-induced seizures,A. pyrethrum root extract
showed a 50, 66.7, 83.3, and 100% protection against GTCS
at doses 50, 100, 250, and 500mg/kg, respectively. In MES
model, the extract produced a 16.7, 33.3, and 50% protec-
tion against THLE at doses of 250, 500, and 1000mg/kg,
respectively. Root extract also significantly prevented seizure-
induced oxidative stress and cognitive impairment in a dose-
dependent manner [12]. Recently Pahuja et al. evaluated the
effect of orally administration of hydroalcoholic extracts of
A. pyrethrum root in the doses of 100, 250 and 500mg/kg in
the PTZ-induced kindling, spatial memory, oxidative stress,
and rho kinase (ROCK II) in albino mice. Pretreatment
with the extract at doses of 250 and 500mg/kg showed
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Table 1: Anticonvulsant studies of the efficacy of medicinal plants in TIM.
Name of plant Part used in TIM Active constituent ExperimentalModel of seizures Clinical trials Reference
Terminalia chebula
(Combretaceae) Fruits Ethanolic extract of fruits
PTZ, MES, and
PC∗ [9]
Anacyclus pyrethrum
(compositae) Root
Chloroform fraction of root
Root ethanolic extract
Hydroalcoholic root extract
PTZ, ICES∗
MES
PTZ, MES
[10–13]
Pimpinella anisum
(Umbelliferae) Seed
Anise seed oil
Methanol seed extract
PTZ, MES
PC [14–17]
Laurus nobilis
(Lauraceae) Fruits (seed) Leaf essential oil PTZ, MES [18]
Origanum majorana
(Labiatae) Aerial parts
Pet ether, chloroform,
acetone, methanol, and
aqueous extracts
PTZ, MES [19]
Nigella sativa
(Ranunculaceae) Seed
Aqueous seed extract
Seed essential oil
PTZ
PTZ
Childhood
refractory
epilepsy
[20–22]
Thymoquinone PTZ, MES
Childhood
refractory
epilepsy
[23–25]
Piper longum
(Piperaceae) Fruits
Aqueous fruit extract
PTZ, strychnine,
and
4-aminopyridine
[26]
Piperine Uncontrolledepilepsy∗∗ [27]
Pilocarpine
Threshold doses of
kainite
L-glutamate,
N-methyl-D-
aspartate
guanidinosuccinate
[28, 29]
Ferula gummosa
(Apiaceae) Gum resin
Fruit essential oil
seed acetone extract
PTZ, MES
PTZ, MES [30–32]
Ferula assa-foetida
(Apiaceae) Gum resin Gum ethanolic extract PTZ [33]
Brassica nigra
(Brassicaceae) Fruits Seed extract PTZ [34]
Caesalpinia bondu-
cella (Caesalpiniaceae) Fruits Seed pet ether extract
PTZ, MES,
strychnine, and PC [35]
Lavandula stoechas
(Lamiaceae) Aerial parts
Aqueous-methanolic
extract of flower PTZ [36]
Ruta graveolens
(Rutaceae) Aerial parts Hydroalcoholic extract PTZ [37]
∗PTZ: pentylenetetrazole, MES: maximum electroshock, PC: picrotoxin, ICES: increasing current electroshock.
∗∗Effect of piperin on oral bioavailability of phenytoin.
significant increase in the myoclonic jerk latency and delay
in the development of kindling. A significant decrease in
mortality was observed at higher doses of the extract (250 and
500mg/kg). Pretreatment with the root extract significantly
increased the number of platform crossings and decreased
the escape latency, as opposed to the PTZ group, thus
showing protection against thememory deficit.The oxidative
stress induced by PTZ kindling is also attenuated. PTZ-
induced kindling increased the ROCK II expression whereas
pretreatment with Anacyclus extract attenuated the increase
in ROCK II expression [13].
3.1.4. Laurus nobilis. Laurus nobilis (Ghar in TIM), Lau-
raceae, is a plant which is mentioned for antiepileptic effects
in the ancient books of Iran. The leaf ’s essential oil of
Laurus nobilis Linn was evaluated for anticonvulsant activity
against experimental seizures. The essential oil protected
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mice against tonic convulsions induced by maximal elec-
troshock and especially by PTZ (ED
50
= 0.19mL/Kg). Com-
ponents responsible for this effect may be methyleugenol,
eugenol, and pinene present in the essential oil. At anticon-
vulsant doses, the essential oil produced sedation and motor
impairment. This effect seems to be related in part to cineol,
eugenol, and methyleugenol. Although the essential oil had
an acceptable acute toxicity, further studies are required
before any absolute conclusions can be drawn [18].
3.1.5. Origanum majorana. The aerial parts of Origanum
majorana (“Marzanjoosh” in TIM) are used for the treatment
of epilepsy and some CNS disorders in TIM.
Anticonvulsant and sedative activities for different
extracts of aerial parts (leaves and stems) of O. majorana
were investigated using the PTZ and maximal electroshock
(MES) test. Different extracts of O. majorana including
pet. ether, chloroform, acetone, methanol, and aqueous
extracts exhibited an anticonvulsant effect in both the PTZ
and MES-induced seizure models at the doses of 250 and
500mg/kg i.p. The extracts of O. majorana delayed the onset
of seizures and reduced the duration of seizures in PTZ test
and decreased the duration of seizures in MES test compared
to the control group. The chloroform extract exhibited a
maximum reduction (58.47 and 44.83% in PTZ and MES
test, resp.) in the duration of seizures. A triterpenoic acid
fraction (TAF) which contained a substantial amount of
ursolic acid was isolated from the chloroformic fraction.
The TAF exhibited a maximum reduction (64.54 and 59.31%
in PTZ and MES test, resp.) in the duration of seizures
compared to the other extracts of O. majorana. Also, the test
extracts decreased the latency and increased the duration
of total sleeping time significantly. Presence of flavonoids,
steroids, triterpenoids, and essential oil may be responsible
for the anticonvulsant activity of this plant [19].
3.1.6. Nigella sativa. The seeds ofNigella sativa, called “Shon-
eez” in TIM, were used in some of the herbal preparations
for the treatment of epilepsy.The anticonvulsant effects of the
aqueous seed extract of Nigella sativa were evaluated using
pentylenetetrazole (PTZ—40mg/kg b.w.) induced seizure
model on adult albino rats.The effects of the extract onmotor
behaviour, sleeping time, seizure parameters (ictal phase
duration, interictal phase duration, and seizure score), and
EEG were studied. The results indicated that Nigella extract
impaired motor coordination, reduced locomotor activity
but increased sleeping time. It also showed the animals
with prior treatment with Nigella extract to have much
resistance to convulsion than the control animals. Ictal phase
duration and severity score decreased whereas interictal
phase duration and duration of onset of seizure increased in
Nigella treated group. In EEG recording spike/wave and burst
discharges were reduced considerably afterNigella treatment.
Picrotoxin, a GABAA antagonist, antagonized the reduction
of seizure activity by N. sativa inhibited the prolongation
of seizure latency. The findings of this study suggest that
N. sativa may have an anticonvulsant activity in the petit
mal epilepsy probably through an increase in GABAergic
tone [20]. Also the anticonvulsant and antioxidant activities
of Nigella seed oil on PTZ-kindling seizures in mice were
investigated compare to valproate. Both Nigella oil and
valproate significantly decreased the oxidative injury in the
mouse brain tissue in comparison with the PTZ-kindling
group. Nigella sativa oil was found to be the most effective in
preventing PTZ-induced seizures relative to valproate.Nigella
sativa oil showed antiepileptogenic properties as it reduced
the sensitivity of kindled mice to the convulsive and lethal
effects of PTZ; valproate was ineffective in preventing the
development of any of these effects [21]. Akhondian et al.
evaluated the efficacy of the aqueous extract of Nigella sativa
in reducing the frequency of seizures in childhood refractory
epilepsy. This study was a double-blinded crossover clinical
trial conducted on children with refractory epilepsy. The
extract was administered as an adjunct therapy, and the
effects were compared with those of a placebo. All the
patients (20 children, 13 months to 13 years old) were
receiving constant treatment for at least one month before
the study. They received extract (40mg/kg/8 h) or placebo
for a period of four weeks, and between these periods for
two weeks they received only their preexisting antiepileptic
drugs (AEDs). The mean frequency of seizures decreased
significantly during the treatment with the extract (𝑃 < 0.05)
so thewater extract ofNigella sativa L. has antiepileptic effects
in children with refractory seizures [22].
Thymoquinone is the major constituent of Nigella sativa
seeds, and anticonvulsant activity of this compound was
evaluated in experimental and clinical studies.
Anticonvulsant activity of thymoquinone was investi-
gated in PTZ and MES models of seizure in dose of 40,
80mg/kg prolong the onset of seizures and reduce the dura-
tion of myoclonic seizures induced by PTZ treatment but not
by MES. But the complete protective effect against mortality
was reported in both tests. In addition this study suggests
that the effect of thymoquinone in PTZ model probably
through an opioid receptor mediated an increase in the
GABAergic tone (base on flumazenil and naloxone response)
[23]. Also the anticonvulsant effect of thymoquinone was
evaluated through intracerebroventricular (i.c.v.) injection
using PTZ-induced seizure model. The i.c.v. injection of
thymoquinone (200 and 400 𝜇mol) prolonged the onset and
reduced the duration of tonic-clonic seizures. The protective
effect of thymoquinone against lethality was 45% and 50%
in the mentioned doses, respectively. In this study, flumaze-
nil (1 nmol, i.c.v.) reversed the anticonvulsant activity of
thymoquinone. Also, pretreatment with naloxone (10𝜇mol,
i.c.v.) antagonized the prolongation of tonic-clonic seizure
latency, as well as reduction in seizure duration both induced
by thymoquinone (200 𝜇mol, i.c.v.). So thymoquinone may
possess anticonvulsant activity probably through an opioid
receptor-mediated increase in GABAergic tone [24].
A pilot, double-blinded crossover clinical trial study
of thymoquinone (1mg/kg) as an adjunctive therapy was
performed on childrenwith refractory epilepsy, and its effects
on frequency of seizures were compared with those of a
placebo. The patients (22 children) were assigned in two
groups and received either thymoquinone or placebo for a
period of four weeks, and then, during the two weeks of wash
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outperiod, they received only their preexisting antiepileptic
drugs; then, after cross-overing, they received thymoquinone
or placebo for a period of four weeks again. During these
periods their effects on seizure frequency were investigated.
The reduction of frequency of seizures at the end of first
period in comparison with the same period before the study
demonstrated a significant difference between two groups
(thymoquinone and placebo) (𝑃 = 0.04). Also the reduction
of the frequency of seizure has shown a significant difference
between the two groups at the end of second period in
comparison with the end of the first period (𝑃 = 0.02)
[25].
3.1.7. Caesalpinia bonducella (L.). Caesalpinia bonducella
(L.) Fleming (Syn. Caesalpinia bonduc (L.) Roxb), known
as “Bandogh Hendi” in TIM, belonging to the family
Caesalpiniaceae, is widely distributed all over the world.
Anticonvulsive effect of the seed petroleum ether extract
of Caesalpinia bonducella was studied using PTZ, MES,
and strychnine- and picrotoxin-induced convulsionsmodels.
Diazepam was used as a standard reference for all models
except maximal electroshock model, wherein phenytoin was
used as standard reference. Seed kernels of C. bonducella
were extracted with solvents like petroleum ether, ethanol,
methanol, and water using soxhlet apparatus. All the extracts
were administered as a suspension in 2% gum acacia in
all the experiments. In PTZ, MES, and strychnine- and
picrotoxin-induced convulsion models medium and high
doses (600 and 800mg/kg) of the petroleum ether extract
showed a significant anticonvulsant activity. The present
study revealed that the petroleum ether extract possessed
anticonvulsant activity which may be contributed to the
presence of phytoconstituents such as saponins, proteins,
homoisoflavone (bonducillin), carbohydrates, and sterols
present in the drug, as these are already reported for their
anxiolytic and anticonvulsant activities [35].
3.1.8. Piper longum. Piper longum known as “Darfelfel” in
TIM. The fruits of Piper longum were used in the treatment
of epilepsy.
An aqueous extract of fruits of Piper longum L. PL was
investigated for its anticonvulsant activity against seizures
induced by PTZ, strychnine, and 4-aminopyridine in mice.
The results revealed that the treatment of groups with the
extract (250mg/kg and 500mg/kg p.o.) offered protection
against PTZ-induced convulsions but failed to protect against
strychnine and 4-aminopyridine-induced convulsions in
mice. Diminution in gamma amino butyric acid (GABA)
levels in the brain of extract the treated mice compared to
vehicle the treated mice clearly indicated the involvement
of GABAergic mechanisms in the anticonvulsant activity
[26].
Piperine, an alkaloid present in the Piper genus, was
shown to have an anticonvulsant activity, evaluated by the
pilocarpine-induced model, in mice. Pilocarpine (350mg/kg
i.p.) was administered 30min after piperine (2.5, 5, 10, and
20mg/kg i.p.) which significantly increased latencies to 1st
convulsion and to death and percentage of survivals. These
parameters were also increased in the pilocarpine groups
pretreated with atropine plus piperine (10 and 2.5mg/kg,
resp.), as related to the pilocarpine group. Moreover, the
pilocarpine group pretreated with diazepam (which binds to
the GABAA receptor, 0.2 and 0.5mg/kg, i.p.) plus piperine (1
and 2.5mg/kg) significantly increased latency to the 1st con-
vulsion, as related to the pilocarpine group, suggesting that
the GABAergic system is involved with the piperine action.
Furthermore, the piperine effect was blocked by flumazenil
(2mg/kg, i.p.), a benzodiazepine antagonist. Untreated P350
animals showed decreased striatal DA and increased DOPAC
and HVA levels that were not affected in the piperine
plus pilocarpine groups. Piperine increased striatal levels
of GABA, glycine and taurine, and reversed pilocarpine-
induced increases in nitrite contents in sera and brain.
Hippocampi from the untreated pilocarpine group showed
an increased number of TNF-𝛼 immunostained cells in all
areas, as opposed to the pilocarpine group pretreated with
piperine. Taken together, piperine anticonvulsant effects are
the result of its anti-inflammatory and antioxidant actions,
as well as TNF-𝛼 reduction. In addition, piperine effects
on inhibitory amino acids and on the GABAergic system
may certainly contribute to the drug’s anticonvulsant activity
[28].
Also piperine has been reported to enhance the oral
bioavailability of phenytoin in human volunteers. The effect
of a single dose of piperine in patients with uncontrolled
epilepsy on the steady-state pharmacokinetics of phenytoin
was evaluated. Two groups of 10 patients each receiving
either a 150mg or 200mg twice daily dose of phenytoin
were selected. Twelve hours after the night dose, venous
blood samples were collected at 0, 0.5, 1, 2, 4, 6, 9, and 12 h
after administration of phenytoin. On the next study day,
piperine 20mg was administered along with phenytoin, and
samples were collected similarly.Themean plasma drug con-
centrations at different time points and the pharmacokinetic
parameters before and after piperine administration were
compared by Student’s t-test. Piperine increased significantly
the mean plasma concentration of phenytoin at most of the
time points in both dose groups. There was a significant
increase in AUC
(0-12 h) (𝑃 < 0.01), 𝐶max (Maximum plasma
concentrations) (𝑃 < 0.001) and 𝐾
𝑎
(The absorption rate
Constant) (𝑃 < 0.05) whereas the changes in 𝐾el (The termi-
nal phase rate constant) and 𝑡max (the time to reach the
maximum concentration) were not significant. The results
showed that piperine enhanced the bioavailability of pheny-
toin significantly, possibly by increasing the absorption [27].
In another study the effects of piperine on convulsions
induced in mice by agonists at different excitatory amino
acid receptor subtypes were studied. Piperine was shown
to significantly block convulsions induced by intracere-
broventricular injection of threshold doses of kainate but
to have no or only slight effects on convulsions induced by
L-glutamate, N-methyl-D-aspartate, or guanidinosuccinate.
Piperine suspensions, injected intraperitoneally, 1 h before
the injection of the threshold intracerebroventricular dose
of kainate for the induction of clonic convulsions (1 nmol),
blocked these convulsions with an ED
50
(and 95% confidence
interval) of 46 (25–86)mg/kg [29].
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3.1.9. Ferula gummosa. “Barijeh” (Traditional name of Fer-
ula gummosa) is a plant which has been mentioned for
antiepileptic properties in TIM. The fruit essential oil of
Ferula gummosa, Umbelliferae, was evaluated for anticonvul-
sant activity against experimental seizures induced by MES
but it had no effect against seizures. However, it protected
mice against PTZ-induced tonic seizures.The protective dose
produced neurotoxicity. Moreover, this dose was too close
to the LD
50
of the essential oil [30]. In another study the
seed acetone extract of F. gummosa protected mice against
tonic convulsions induced by maximal electroshock (ED
50
= 198.3mg/kg) and especially by pentylenetetrazole (ED
50
=
55mg/kg). Neurotoxicity (sedation and motor impairment)
of the extract was assessed by the rotarod test, and the
median toxic dose (TD
50
) value of 375.8mg/kg was obtained
[31]. Also anticonvulsant effect of the root acetone extract
of F. gummosa (300–500mg/Kg i.p.) was evaluated in PTZ
and MES models of seizure. The extract showed dose-
dependent prevention of tonic seizures induced by PTZ
(ED
50
= 154.4mg/kg. Ferula root extract also showed a
significant protective effect against MES-induced seizures at
doses of 500 and 750mg/kg, and the higher doses were toxic)
[32].
3.1.10. Ferula Assa-Foetida. Ferula assafoetida known as
“Anghose” in TIM is another herbal drug for treatment
of epilepsy. The anticonvulsant effect of F. assa foethica
gum ethanolic extract was investigated using PTZ-induced
kindling method in male mice. The animals were divided
into 6 experimental groups (𝑛 = 10 in each group),
that is, 1—control, 2—PTZ, 3, 4, and 5—treatment groups
which received the extract in 25, 50 and 100mg/kg; i.p,
respectively, and 6—positive control group which received
valproate (100mg/kg) as an anticonvulsant drug. All groups
were kindled by 11-period injection of PTZ (35mg/kg i.p.). In
the 12th injection, all groups were tested for PTZ challenge
dose (75mg/kg). However, exhibited phase of seizure (0–5)
was observed and noted till 30min after PTZ injection. The
results showed that the F. foetida gum extract has a reduction
effect on seizure intensity, progression, and duration [33].
3.1.11. Lavandula stoechas. Lavandula stoechas L. (Lami-
aceae), known as “Ostokhoddos” in TIM, was mentioned
in TIM for epilepsy. The aqueous-methanolic extract of L.
stoechas flowers was studied for its possible anticonvulsant
and antispasmodic activities.When tested inmice, the extract
(600mg/kg) significantly reduced the severity and increased
the latency of convulsions induced by PTZ and also reduced
PTZ’s lethality. L. stoechas extract up to a dose of 600mg/kg
was found devoid of any hypnotic effect in mice; however,
animals were found to be dull, calm, and relaxed.The sedative
effect of the plant extract was confirmed, as it prolonged
the pentobarbital sleeping time in mice similar to that of
diazepam [36].
3.1.12. Brassica nigra. Brassica nigra (“Khardal” in TIM)
is one of the antiepileptic agents in TIM. In a study by
Kiasalari et al., the anticonvulsant effect of Brassica nigra
was investigated by kindling method. Sixty male mice were
divided into six experimental groups (𝑛 = 10) including
1—control, 2—pentylentetrazole (PTZ)-kindled mice, 3—
positive control group received valproate (100mg/Kg) as an
anticonvulsant drug, and 4-5 and 6 received Brassica nigra
seed extract in three doses (75, 150 and 300mg/Kg; IP). All
groups (except for the control ones) were kindled by 11-period
injections of PTZ (35mg/Kg; IP). In the 12th injection, all
groups except for the control group were tested for PTZ
challenge dose (75mg/Kg). However, the exhibited phases of
seizure (0–6) were observed and noted till 30min after the
PTZ injection.At last, the brains of all themicewere removed,
and then malondialdehyde (MDA), superoxide dismutase
(SOD), and nitric oxide (NO) levels of the brain tissues were
determined. Statistical analysis of the data shows that the
seed extract could reduce the intensity, improvement, and
duration of seizure. In addition, the Brassica nigra extract
increased the SOD and NO levels and decreased the MDA
level in the brain tissues. Attained results show that the extract
of Brassica nigra seed can be used in grand mal seizure
treatment. Moreover, the antiepileptic effect of this extract
is probably caused by its antioxidant properties and acts via
enzyme activity mechanism [34].
3.1.13. Ruta graveolens. “Sodab” is a traditional name of Ruta
graveolens in TIM. It is an another remedy for epilepsy
in Iranian traditional books. The anticonvulsant effects of
hydroalcoholic extract of rue (Ruta graveolens) were inves-
tigated in male mice by PTZ-induced seizure. Case groups
(five groups) have been injected by 100, 300, 500, 800,
and 1000mg/kg of extracts, positive control group 40mL/kg
phenobarbital and negative control group 10mL/kg normal
saline intraperitoneally. All groups were injected by PTZ
(80mg/kg) intraperitoneally after 45 minutes, and initiation
time of myocolnic and tonic-colonic seizures and rate of 24-
hour death were measured. hydroalcoholic extracts of rue
increased the delay in initiation of myocolonic and tonic-
colonic seizures rather than control group dose-dependently
and reduced 24-hour seizure induced mortality (𝑃 < 0.05).
Delay in myocolonic seizures in doses of 300, 500, 800, and
1000mg/kg (𝑃 < 0.001) and 100mg/kg (𝑃 < 0.01) was
significant in comparison with negative control group. Delay
in tonic-colonic seizures in dose of 1000mg/kg (𝑃 < 0.001)
and doses of 300, 500, and 800mg/kg (𝑃 < 0.05) was
significant in comparison with negative control group. So, it
seems that the extract of this herb has a decremental effect on
PTZ induced seizure in male adult mice [37].
4. Conclusion
Epilepsy is one of the most common neurological disorders
which affect about 50 million people worldwide [1]. Ineffec-
tiveness of the antiepileptic drugs in nearly 20% of the cases
and the serious side effects and chronic toxicity of these drugs
lead to the use of complementary and alternative medicine as
a new method for treatment of epilepsy.
TIM consists of the sum total of all the knowledge and
practices used in diagnosis, prevention, and elimination in
BioMed Research International 7
Persia from ancient times to present. In this article the
antiepileptic herbs of TIM and modern evidence for the
efficacy of them were reviewed based on the published
studies.
There are somemedicinal plants in TIM for the treatment
of epilepsy which their anticonvulsant effect have been
confirmed by scientific studies in experimental or clinical
studies (Table 1). The anticonvulsant effect of some of these
medicinal plants like Anacyclus pyrehrun, Pimpinella anisum,
Nigella sativa, and Ferula gummosa was studied in more than
one study with different models of seizure. Also for some of
these plants likeNigella sativa or Piper longum the active con-
stituent responsible for the antiepileptic effect was isolated
and studied in different models of seizures. Identification and
isolation of the active compounds of the other antiepileptic
plants could be performed in future studies.
For some of the herbal products used in TIM such as
Pistacia lentiscus gum (Mastaki), Bryonia alba (Fashra), Fer-
ula persica (Sakbinaj), Ecbalium elaterium (Ghesa-al Hemar),
and Alpinia officinarum (Kholanjan), there are no or not
enough studies to confirm their benefits in epilepsy. It is
suggested that an evaluation of the effects of these plants on
different models of epilepsy should be performed.
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